|
PIGG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28180000011658E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.63010000004049E-06 |
| Normal-vs-Stage2 |
8.200400E-02 |
| Normal-vs-Stage3 |
2.15699999972507E-07 |
| Normal-vs-Stage4 |
1.73405999999154E-05 |
| Stage1-vs-Stage2 |
5.106000E-01 |
| Stage1-vs-Stage3 |
7.039600E-02 |
| Stage1-vs-Stage4 |
2.545400E-01 |
| Stage2-vs-Stage3 |
1.397610E-01 |
| Stage2-vs-Stage4 |
2.096400E-01 |
| Stage3-vs-Stage4 |
8.292400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.98940000040571E-07 |
| Normal-vs-AfricanAmerican |
9.399900E-02 |
| Normal-vs-Asian |
4.319300E-03 |
| Caucasian-vs-AfricanAmerican |
9.572000E-02 |
| Caucasian-vs-Asian |
2.160600E-01 |
| AfricanAmerican-vs-Asian |
5.279200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.179400E-04 |
| Normal-vs-Female |
2.75919999959129E-07 |
| Male-vs-Female |
5.025000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.0913999999882E-06 |
| Normal-vs-Age(41-60Yrs) |
2.218000E-04 |
| Normal-vs-Age(61-80Yrs) |
8.18269999980359E-07 |
| Normal-vs-Age(81-100Yrs) |
1.566080E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.974400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.132800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.059600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.054000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.287000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.924200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.60710000044418E-07 |
| Classical-VS-Follicular |
5.664000E-01 |
| Classical-VS-Other |
2.432800E-01 |
| Classical-VS-Normal |
4.362100E-04 |
| Tall-VS-Follicular |
1.883570E-03 |
| Tall-VS-Other |
6.192800E-01 |
| Tall-VS-Normal |
2.37969643990255E-11 |
| Follicular-VS-Other |
4.500000E-01 |
| Follicular-VS-Normal |
6.610900E-04 |
| Other-VS-Normal |
4.381200E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.25169999999997E-05 |
| Normal-vs-N1 |
4.40159999559597E-08 |
| N0-vs-N1 |
1.812220E-02 |
|
|
